News Conference News CRT 2026 TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide L.A. McKeown March 19, 2026
News Conference News CRT 2026 PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years L.A. McKeown March 17, 2026
News Conference News CRT 2026 SOLVE-TAVI: Patient Sex, for the Most Part, Doesn’t Sway Outcomes by Valve Type L.A. McKeown March 16, 2026